Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report

  • Elahe Sasani Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  • Sadegh Khodavaisy Zoonoses Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammadreza Salehi Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Sareh Bagheri-Josheghani Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
  • Mahsa Abdorahimi Department of Microbiology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran
  • Seyed Ali Dehghan Manshadi Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Alireza Abdollahi Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Amir Salami Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Marjan Sohrabi Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Salami Khaneshan Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Pulmonary; Aspergillosis; Tuberculosis; COVID-19; Coinfection

Abstract

Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.

Published
2024-06-21
Section
Articles